LeMaitre Vascular (LMAT) News Today $102.02 +0.50 (+0.49%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Los Angeles Capital Management LLCLos Angeles Capital Management LLC raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 23.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,656 shares of the medicalNovember 13, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Raised to Buy at StockNews.comNovember 10, 2024 | americanbankingnews.comPortside Wealth Group LLC Purchases New Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Portside Wealth Group LLC acquired a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,352 shares of the medical instruments supplier's stock, valued at approximately $497,00November 9, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High - Should You Buy?LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week High - Here's What HappenedNovember 8, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Consensus Price Target from BrokeragesNovember 8, 2024 | americanbankingnews.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Harbor Capital Advisors Inc.Harbor Capital Advisors Inc. grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 113.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,093 shares of the medical instruments supplierNovember 5, 2024 | marketbeat.comFY2024 EPS Forecast for LeMaitre Vascular Boosted by AnalystLeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Equities researchers at Barrington Research lifted their FY2024 earnings per share (EPS) estimates for LeMaitre Vascular in a note issued to investors on Friday, November 1st. Barrington Research analyst M. Petusky now forecasts that the medicNovember 4, 2024 | marketbeat.comLeMaitre Vascular: The Market Is Catching On To This Dividend Growth StoryNovember 3, 2024 | seekingalpha.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from AnalystsLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, six have given aNovember 3, 2024 | marketbeat.comLeMaitre Vascular Third Quarter 2024 Earnings: Beats ExpectationsNovember 2, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans $0.16 Quarterly DividendLeMaitre Vascular, Inc. (NASDAQ:LMAT) announced a quarterly dividend on Thursday, October 31st. Stockholders of record on Thursday, November 21st will be paid a dividend of 0.16 per share by the medical instruments supplier on Thursday, December 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Thursday, November 21st.November 2, 2024 | marketbeat.comF M Investments LLC Has $11.48 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)F M Investments LLC lifted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 36.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 123,545 shares of the medical iNovember 2, 2024 | marketbeat.comKeyBanc Remains a Hold on Lemaitre Vascular (LMAT)November 2, 2024 | markets.businessinsider.comLemaitre Vascular (LMAT) Gets a Buy from Stifel NicolausNovember 2, 2024 | markets.businessinsider.comIn-Depth Examination Of 4 Analyst Recommendations For LeMaitre VascularNovember 2, 2024 | benzinga.comLeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...November 2, 2024 | finance.yahoo.comLeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its quarterly earnings results on Thursday. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.05. LeMaitre Vascular had a net margin of 18.33% and a return on equity of 12.41%. The firm had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million. During the same period in the previous year, the business earned $0.33 EPS. The company's revenue was up 15.6% compared to the same quarter last year.November 1, 2024 | marketbeat.comLeMaitre to Participate at Upcoming Investor Conferences in NovemberNovember 1, 2024 | globenewswire.comLeMaitre Vascular (NASDAQ:LMAT) Earns Outperform Rating from OppenheimerOppenheimer reiterated an "outperform" rating and issued a $93.00 target price (up from $90.00) on shares of LeMaitre Vascular in a report on Friday.November 1, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Conestoga Capital Advisors LLCConestoga Capital Advisors LLC grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 1.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,978,351 shares of the medical instrumentsNovember 1, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Given New $93.00 Price Target at Barrington ResearchBarrington Research upped their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an "outperform" rating in a research report on Friday.November 1, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High on Earnings BeatLeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High After Better-Than-Expected EarningsNovember 1, 2024 | marketbeat.comLemaitre Vascular: Strong Buy Rating Supported by Robust Financials and Strategic Growth InitiativesNovember 1, 2024 | markets.businessinsider.comLeMaitre Q3 2024 Financial ResultsOctober 31, 2024 | globenewswire.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Increased by Congress Asset Management Co.Congress Asset Management Co. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 709,316 shares of the medical instruments supplier'October 31, 2024 | marketbeat.comLeMaitre Vascular Q3 2024 Earnings PreviewOctober 31, 2024 | msn.comSmith Group Asset Management LLC Invests $573,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Smith Group Asset Management LLC purchased a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,169 shares of the medical instrumenOctober 29, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Position Boosted by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 73.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,848 shares of tOctober 26, 2024 | marketbeat.comAusbil Investment Management Ltd Lowers Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Ausbil Investment Management Ltd lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 63.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,246 shares of the medical inOctober 24, 2024 | marketbeat.comLeMaitre Vascular (LMAT) to Release Quarterly Earnings on ThursdayLeMaitre Vascular (NASDAQ:LMAT) will be releasing earnings after the market closes on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=481515)October 24, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) is Copeland Capital Management LLC's 4th Largest PositionCopeland Capital Management LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 1.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,163,392 shares of the medical instruments supplier's stock after purchasing an additionaOctober 22, 2024 | marketbeat.comBrokers Issue Forecasts for LeMaitre Vascular, Inc.'s FY2024 Earnings (NASDAQ:LMAT)LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for LeMaitre Vascular in a note issued to investors on Tuesday, October 15th. Cantor Fitzgerald analyst R. Osborn expects that the medical instrumentOctober 17, 2024 | marketbeat.comCantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral RecommendationOctober 17, 2024 | msn.comLeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024October 15, 2024 | globenewswire.comAnalyst Scoreboard: 4 Ratings For LeMaitre VascularOctober 15, 2024 | benzinga.comCantor Fitzgerald Begins Coverage on LeMaitre Vascular (NASDAQ:LMAT)Cantor Fitzgerald initiated coverage on LeMaitre Vascular in a research note on Tuesday. They issued a "neutral" rating and a $96.00 price target on the stock.October 15, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Millennium Management LLCMillennium Management LLC lessened its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 30.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 76,205 shares of the medical instruments supplier's stock after selliOctober 11, 2024 | marketbeat.comAQR Capital Management LLC Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)AQR Capital Management LLC raised its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 68.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,569 shares of the medical instruments supplier's stock afOctober 10, 2024 | marketbeat.comLeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ...October 9, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Buy" by AnalystsShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have been assigned a consensus rating of "Buy" from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have given a buy reOctober 9, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Position Decreased by Marshall Wace LLPMarshall Wace LLP lowered its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 44.3% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,019 shares of the medical instruments supplier's stock afteOctober 5, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comLeMaitre Vascular (NASDAQ:LMAT) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comAlgert Global LLC Has $2.91 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Algert Global LLC lessened its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 16.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 35,417 shares of the medical instruments supplier's stock after selling 7,189 shares during the periOctober 2, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Sets New 12-Month High at $93.07LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week High at $93.07September 30, 2024 | marketbeat.comLeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals?September 29, 2024 | finance.yahoo.comDriehaus Capital Management LLC Has $21.74 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Driehaus Capital Management LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 52.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 264,217 shares of the medical instruments supplier's sSeptember 29, 2024 | marketbeat.comAlpha DNA Investment Management LLC Buys New Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Alpha DNA Investment Management LLC purchased a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the second quarter, according to its most recent filing with the SEC. The firm purchased 6,069 shares of the medical instruments supplier's stock, valued at approximatelySeptember 25, 2024 | marketbeat.comLemaitre Vascular’s Growth Prospects Bolstered by Pricing Power and Strategic Expansion: A Buy Rating ReviewSeptember 21, 2024 | markets.businessinsider.comLeMaitre Vascular (NASDAQ:LMAT) Rating Reiterated by Barrington ResearchBarrington Research reaffirmed an "outperform" rating and set a $92.00 price target on shares of LeMaitre Vascular in a research note on Friday.September 20, 2024 | marketbeat.com Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide LMAT Media Mentions By Week LMAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼1.300.55▲Average Medical News Sentiment LMAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼34▲LMAT Articles Average Week Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VAPO News TFX News PEN News GKOS News STVN News MMSI News INSP News PRCT News HAE News ICUI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
